Integrated Services Facilities Quality System Environmental & Health Safety Project Management FAQ
  Overview
  Manufacturing Services
  Chemistry Services
  Pharmaceutical Services
  Analytical Services
  Regulatory Services
  Flex FTE
  AsymFile
  Overview
  Capacity of Chemical Synt...
  R&D and Kilo Labs
  cGMP Kilo Facilities
  Pilot Plant Units
  Bulk Production
  High Potency Facilities
  Expansion Plan
  EHS Overview
  EHS: Waste Treatment & Di...
  SEPA Testing
  REACH
  Overview
  RFQ
  Communication
  Delivery
  IP Control
Our Company
Our Management
Corporate Culture
Our Accomplishments
Customer Testimonials
Press Releases
Video
Brochure
  > HOME
News
 
Dr. Chris Huber joins Asymchem Laboratories Inc. as Director of Chemical Development
2009-04-23

April 23, 2009 in Morrisville, NC

Morrisville, NC, USA, April 23, 2009: Asymchem Laboratories, Inc, a leading research-based contract manufacturer of API’s, intermediates and Drug Products to the pharmaceutical industry, with sites in the U.S. and China, is pleased to announce the recent addition of Dr. Chris Huber as Director of Chemical Development.

Dr. Huber brings to the table over 15 years experience in the pharmaceutical industry (early and late stage), developing process technology for API manufacturing of small molecules. Prior to Asymchem, Dr. Huber directed early phase projects for API manufacturing at Achaogen Inc. and Arena Pharmaceuticals. Much of his career was spent in Pfizer and legacy companies in process chemistry, with focus on optimization, characterization and validation of Phase 3 processes in preparation for commercial manufacturing of API.

As Director of Chemical Development, Dr. Huber will help expand and strengthen Asymchem’s pilot scaleup, tech transfers and production efforts into commercial manufacturing. He will report directly to Dr. Jim Gage, VP of Chemical Development.

“I am very pleased to have Dr. Huber on board to help expand and strengthen Asymchem’s already well-established large scale manufacturing services,” states Dr Hao Hong, CEO of Asymchem.  “With his broad experience in the pharmaceutical industry and proven track record of API manufacturing, I am confident that our commercial capabilities will be further strengthened and solidified.”

Dr. Huber received his B.S. and M.S. at the Universität Regensburg , Germany under the supervison of Professors Dr. Henri Brunner, Dr. Jürgen Sauer and Dr. Josef Barthel. He earned his  Ph.D. in Organic Chemistry and Catalysis from the Universität Regensburg, Germany with Professor Dr. Henri Brunner.  He did his postdoc at Purdue University, Indiana under Professor Thomas Bein on the development of supported organometallic catalysts with application in organic synthesis.

Asymchem Laboratories is a leading research-based contract manufacturer specialized in the development and compliant manufacturing (Contract Research and Manufacturing Services) of API’s and Drug Products serving the pharmaceutical industry. With a 14yr track record, Asymchem is committed to the highest level of quality and excellence in the integrated CMC services arena.

600 Airport Blvd. Suite 1000 Morrisville, NC 27560 USA Fax:(919)468-3916
Copyright ©2008 Asymchem Laboratories Inc.All rights reserved.